Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target

Secretory clusterin (sCLU) is associated with hepatocellular carcinoma (HCC) progression by contributing to angiogenesis, chemoresistance, cell survival, and metastasis. However, the sCLU expression at early stage of HCC progression remains to be clarified. In this study, the alteration of sCLU onco...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Zheng, Wenjie, Yao, Min, Qian, Qi, Sai, Wenli, Qiu, Liwei, Yang, Junling, Wu, Wei, Dong, Zhizhen, Yao, Dengfu
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581031/
https://ncbi.nlm.nih.gov/pubmed/28881732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13674
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items